Tetraphase, Aratana Make IPO Announcements
BRIEF: Tetraphase, Aratana Make IPO Announcements [Boston Herald]
From Boston Herald (MA) (March 21, 2013)
March 20--Tetraphase Pharmaceuticals Inc. today announced the pricing of its initial public offering of 10.7 million shares of common stock at $7 per share.
Tetraphase’s common stock is expected to begin trading on the NASDAQ under the symbol "TTPH" today. The company has granted the underwriters a 30-day option to buy up to 1.6 million additional shares of common stock at the same price to cover over allotments.
Tetraphase is a clinical-stage biopharmaceutical company that creates antibiotics to treat serious and life-threatening multi-drug resistant infections.
Meanwhile, Aratana Therapeutics, a Kansas City, Kansas-based company which recently returned to the Hub to try to adapt drugs made for humans into treatments for cats and dogs, said today it has filed a registration statement with the U.S. Securities and Exchange Commission relating to the company’s proposed initial public offering of common stock.
The number of shares to be offered and the price range for the proposed offering have not yet been determined, Aratana officials said.
(c)2013 Boston Herald
Visit the Boston Herald at www.bostonherald.com
Distributed by MCT Information Services
Posted: March 2013